To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

103.5018 hours ago
108.50a day ago
arrow

LOWER/UPPER CIRCUITS

102.12
112.87
arrow
Ind Swift Laboratories Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 6.89%, in the last year to ₹1,326.27 Cr. Its sector's average revenue growth for the last fiscal year was 10.77%.
noteAnnual Net Profit,rose 784.44% in the last year to ₹420.96 Cr. Its sector's average net profit growth for the last fiscal year was 38.71%.
notePrice to Earning Ratio,is 2.91, lower than its sector PE ratio of 43.25.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 20.57%
Net profit growth 5Y CAGR : 61.43%
Headquartered in Chandigarh India Ind-Swift Laboratories Ltd is a public limited company incorporated on January 04 1995 under the provision of companies Act 2013. The company is global manufacturer of APIs Intermediates and formulations (through group collaboration). Having commenced operations in 1997 as an API manufacturer the company continued to focus on this business domain as its key business driver. Ind-Swift Laboratories is one of the leading API manufacturers in India with a presence in high-value high-growth therapeutic segments.
personal

Grow your wealth with more research recommendations

+91